Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
30 years after the first conference, the Association for Machine Translation in the Americas (AMTA) convened to discuss challenges and opportunities in MT. Google researchers reveal that verbose large ...